- Home
- FMY vs OVID Comparison
FMY vs OVID Comparison
Compare FMY & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- OVID
- Stock Information
- Founded
- FMY 2005
- OVID 2014
- Country
- FMY United States
- OVID United States
- Employees
- FMY N/A
- OVID N/A
- Industry
- FMY Finance/Investors Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- FMY Finance
- OVID Health Care
- Exchange
- FMY Nasdaq
- OVID Nasdaq
- Market Cap
- FMY 50.9M
- OVID 47.1M
- IPO Year
- FMY N/A
- OVID 2017
- Fundamental
- Price
- FMY $12.10
- OVID $0.62
- Analyst Decision
- FMY
- OVID Strong Buy
- Analyst Count
- FMY 0
- OVID 6
- Target Price
- FMY N/A
- OVID $4.03
- AVG Volume (30 Days)
- FMY 10.1K
- OVID 470.8K
- Earning Date
- FMY 01-01-0001
- OVID 03-07-2025
- Dividend Yield
- FMY 6.98%
- OVID N/A
- EPS Growth
- FMY N/A
- OVID N/A
- EPS
- FMY N/A
- OVID N/A
- Revenue
- FMY N/A
- OVID $631,695.00
- Revenue This Year
- FMY N/A
- OVID $71.38
- Revenue Next Year
- FMY N/A
- OVID N/A
- P/E Ratio
- FMY N/A
- OVID N/A
- Revenue Growth
- FMY N/A
- OVID 113.21
- 52 Week Low
- FMY $10.71
- OVID $0.56
- 52 Week High
- FMY $12.17
- OVID $3.79
- Technical
- Relative Strength Index (RSI)
- FMY 52.99
- OVID 38.62
- Support Level
- FMY $12.01
- OVID $0.56
- Resistance Level
- FMY $12.16
- OVID $0.67
- Average True Range (ATR)
- FMY 0.11
- OVID 0.06
- MACD
- FMY -0.00
- OVID 0.00
- Stochastic Oscillator
- FMY 59.79
- OVID 35.94
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.